Get the Stockscreener App
2.70
3.91%
-0.11
After Hours:
2.75
0.05
+1.85%
Tuhura Biosciences Inc stock is traded at $2.70, with a volume of 220.23K.
It is down -3.91% in the last 24 hours and up +0.75% over the past month.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
See More
Previous Close:
$2.81
Open:
$2.81
24h Volume:
220.23K
Relative Volume:
0.50
Market Cap:
$140.63M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-16.92%
1M Performance:
+0.75%
6M Performance:
+7.14%
1Y Performance:
+0.00%
1-Day Range:
$2.69
$2.82
1-Week Range:
$2.69
$3.20
52-Week Range:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences Inc
Sector
Industry
Phone
813-875-6600
Address
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.70 | 140.63M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-03-25 | Initiated | H.C. Wainwright | Buy |
| Dec-19-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-05-24 | Initiated | Maxim Group | Buy |
Tuhura Biosciences Inc Stock (HURA) Latest News
Will breakout in TuHURA Biosciences Inc. lead to full recoveryJuly 2025 Summary & Real-Time Stock Price Movement Reports - Newser
TuHURA Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers Say2025 Momentum Check & AI Enhanced Execution Alerts - Newser
TuHURA Biosciences Inc. stock chart pattern explainedEarnings Growth Report & Entry Point Confirmation Alerts - Newser
Long term hold vs stop loss in TuHURA Biosciences Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
How to forecast TuHURA Biosciences Inc. trends using time seriesWeekly Market Summary & Reliable Breakout Stock Forecasts - Newser
What does recent volatility data suggest for TuHURA Biosciences Inc.Dollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Building trade automation scripts for TuHURA Biosciences Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - Newser
Relative strength of TuHURA Biosciences Inc. in sector analysis2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser
How moving averages guide TuHURA Biosciences Inc. tradingMarket Sentiment Summary & High Return Trade Opportunity Guides - Newser
Top chart patterns to watch in TuHURA Biosciences Inc.2025 Top Gainers & High Conviction Investment Ideas - Newser
TuHURA Biosciences Inc. stock prediction for this weekMarket Risk Analysis & Fast Moving Trade Plans - Newser
Identifying reversal signals in TuHURA Biosciences Inc.July 2025 Update & Fast Gain Swing Alerts - Newser
Earnings Chart Overlay Points to TuHURA Biosciences Inc. Upside getLinesFromResByArray error: size == 0 - thegnnews.com
Historical volatility pattern of TuHURA Biosciences Inc. visualizedJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
TuHURA Biosciences Inc. stock daily chart insightsWeekly Market Outlook & Daily Price Action Insights - Newser
Does TuHURA Biosciences Inc. stock have upside surprise potentialWeekly Profit Recap & Verified Chart Pattern Trade Signals - sundaytimes.kr
How to interpret RSI for TuHURA Biosciences Inc. stockWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Technical signs of recovery in TuHURA Biosciences Inc.July 2025 Pullbacks & Proven Capital Preservation Tips - Newser
TuHURA Biosciences Inc. stock trend forecastWeekly Trading Summary & Real-Time Volume Trigger Notifications - Newser
Is TuHURA Biosciences Inc. stock poised for growth2025 Winners & Losers & Verified Technical Signals - Newser
Will TuHURA Biosciences Inc. outperform its industry peers2025 Price Momentum & Detailed Earnings Play Strategies - sundaytimes.kr
Pattern recognition hints at TuHURA Biosciences Inc. upsideJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser
Can trapped investors hope for a rebound in TuHURA Biosciences Inc.Trend Reversal & Verified Trade Idea Suggestions - Newser
Trend Reversal Possible in TuHURA Biosciences Inc. Charts Indicate getLinesFromResByArray error: size == 0 - classian.co.kr
Applying sector rotation models to TuHURA Biosciences Inc.IPO Watch & Weekly Chart Analysis and Trade Guides - Newser
Combining machine learning predictions for TuHURA Biosciences Inc.Quarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Tuhura Biosciences Inc Stock (HURA) Financials Data
There is no financial data for Tuhura Biosciences Inc (HURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):